{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:13:49Z","timestamp":1649070829398},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jtcvs.2015.12.010","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T01:26:03Z","timestamp":1450229163000},"page":"1200-1202","source":"Crossref","is-referenced-by-count":0,"title":["Returning to the bench with adeno-associated virus 1 SERCA2a gene therapy"],"prefix":"10.1016","volume":"151","author":[{"given":"Leora B.","family":"Balsam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Abe","family":"DeAnda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2015.12.010_bib1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib2","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","author":"Goldstein","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jtcvs.2015.11.031","article-title":"Mitigation of myocardial fibrosis by molecular cardiac surgery mediated gene overexpression","volume":"151","author":"Katz","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jtcvs.2014.05.070","article-title":"Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca2+ adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy","volume":"148","author":"Katz","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.athoracsur.2013.04.021","article-title":"Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure","volume":"96","author":"Fargnoli","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1510\/icvts.2010.244301","article-title":"Gene therapy during cardiac surgery: role of surgical technique to minimize collateral organ gene expression","volume":"11","author":"Katz","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchf.2013.09.008","article-title":"Design of a phase 2b trial of intracoronary administration of AAV1\/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease Phase 2b)","volume":"2","author":"Greenberg","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jtcvs.2015.12.010_bib10","unstructured":"Celladon Corporation. About us. Available at: http:\/\/www.celladon.com\/about-us\/. Accessed December 6, 2015."}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522315023934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522315023934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:22:44Z","timestamp":1537143764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522315023934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0022522315023934"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2015.12.010","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}